These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 9234917

  • 1. Stage IB and IIA cervical cancer with negative lymph nodes: the role of adjuvant radiotherapy after radical hysterectomy.
    Schorge JO, Molpus KL, Koelliker D, Nikrui N, Goodman A, Fuller AF.
    Gynecol Oncol; 1997 Jul; 66(1):31-5. PubMed ID: 9234917
    [Abstract] [Full Text] [Related]

  • 2. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
    Sartori E, Tisi G, Chiudinelli F, La Face B, Franzini R, Pecorelli S.
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
    [Abstract] [Full Text] [Related]

  • 3. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy.
    Ho CM, Chien TY, Huang SH, Wu CJ, Shih BY, Chang SC.
    Gynecol Oncol; 2004 May; 93(2):458-64. PubMed ID: 15099962
    [Abstract] [Full Text] [Related]

  • 4. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
    Tsai CS, Lai CH, Wang CC, Chang JT, Chang TC, Tseng CJ, Hong JH.
    Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
    [Abstract] [Full Text] [Related]

  • 5. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT, Hsu JC, Liu WS, Wang AY, Huang WT, Chang TH, Pi CP, Huang CY, Huang CC, Chou PH, Chen TH.
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [Abstract] [Full Text] [Related]

  • 6. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
    Aoki Y, Sasaki M, Watanabe M, Sato T, Tsuneki I, Aida H, Tanaka K.
    Gynecol Oncol; 2000 May; 77(2):305-9. PubMed ID: 10785483
    [Abstract] [Full Text] [Related]

  • 7. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
    Monk BJ, Cha DS, Walker JL, Burger RA, Ramsinghani NS, Manetta A, DiSaia PJ, Berman ML.
    Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
    [Abstract] [Full Text] [Related]

  • 8. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
    Rutledge TL, Kamelle SA, Tillmanns TD, Gould NS, Wright JD, Cohn DE, Herzog TJ, Rader JS, Gold MA, Johnson GA, Walker JL, Mannel RS, McMeekin DS.
    Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
    [Abstract] [Full Text] [Related]

  • 9. Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement.
    Mariani A, Webb MJ, Keeney GL, Calori G, Podratz KC.
    Gynecol Oncol; 2001 Oct; 83(1):72-80. PubMed ID: 11585416
    [Abstract] [Full Text] [Related]

  • 10. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.
    Samlal RA, van der Velden J, Ten Kate FJ, Schilthuis MS, Hart AA, Lammes FB.
    Cancer; 1997 Oct 01; 80(7):1234-40. PubMed ID: 9317173
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
    Havrilesky LJ, Leath CA, Huh W, Calingaert B, Bentley RC, Soper JT, Alvarez Secord A.
    Gynecol Oncol; 2004 May 01; 93(2):429-34. PubMed ID: 15099957
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
    Uno T, Ito H, Itami J, Yasuda S, Isobe K, Hara R, Sato T, Minoura S, Shigematsu N, Kubo A.
    Anticancer Res; 2000 May 01; 20(3B):2235-9. PubMed ID: 10928184
    [Abstract] [Full Text] [Related]

  • 15. Clinical outcomes and prognostic factors of node-negative cervical cancer patients with deep stromal invasion or lymphovascular space involvement following radical hysterectomy.
    Suprasert P, Srisomboon J, Siriaunkgul S, Khunamornpong S, Phongnarisorn C, Siriaree S, Charoenkwan K, Cheewakriangkrai C, Kietpeerakool C.
    J Med Assoc Thai; 2006 Sep 01; 89(9):1368-75. PubMed ID: 17100371
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
    Zhang WH, Wu LY, Bai P, Li SM, Zhang R, Li B, Sun JH, Wu AR.
    Zhonghua Zhong Liu Za Zhi; 2004 Aug 01; 26(8):490-2. PubMed ID: 15555341
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
    Denschlag D, Gabriel B, Mueller-Lantzsch C, Tempfer C, Henne K, Gitsch G, Hasenburg A.
    Gynecol Oncol; 2005 Mar 01; 96(3):658-64. PubMed ID: 15721408
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.